GELSTAT CORP
OperatingBiotech · Miami, FL
Financials
FY2020–FY2024 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Dec 31, 2022| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Common Stock | 686,179,300 | — | 100.0% | $0.01Oct 2021 |
Principal holders% as the filing states it, Nov 21, 2012
- William Brisben5 Common Stock28.0%of company
- Gerald N. Kieft1 Common Stock23.0%of company
- Adrian G. Goldfarb3 Common Stock4%of company
- William R. Colucci2 Common Stock1%of company
- Paul W. Bucha4 Common Stock0.04%of company
Sold to the crowd
- Reg A+ · Oct 202110,000,000 Common at $0.01$100K
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
4 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 31 filings on EDGAR- Form 1-ZMay 11, 20260001079973-26-000628EDGAR
- Form 1-UApr 30, 20260001079973-26-000584EDGAR
- Form 1-SASep 29, 20250001079973-25-001508EDGAR
- Form 1-KApr 29, 20250001079973-25-000707EDGAR
- Form 1-SASep 26, 20240001553350-24-000112EDGAR
- Form 1-KMay 7, 20240001079973-24-000656EDGAR
- Form 1-UNov 28, 20230001079973-23-001662EDGAR
- Form 1-SAOct 12, 20230001079973-23-001417EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.